TNSN87033A1 - TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES - Google Patents

TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES

Info

Publication number
TNSN87033A1
TNSN87033A1 TNTNSN87033A TNSN87033A TNSN87033A1 TN SN87033 A1 TNSN87033 A1 TN SN87033A1 TN TNSN87033 A TNTNSN87033 A TN TNSN87033A TN SN87033 A TNSN87033 A TN SN87033A TN SN87033 A1 TNSN87033 A1 TN SN87033A1
Authority
TN
Tunisia
Prior art keywords
desα
tolunitriles
heterocycles
substituted
compounds
Prior art date
Application number
TNTNSN87033A
Other languages
English (en)
Inventor
Mathews Bowman Robert
Edward Steele Ronald
Johnston Browne Leslie
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25274596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN87033(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of TNSN87033A1 publication Critical patent/TNSN87033A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LES COMPOSES DE FORMULE I, DANS LAQUELLE LES GROUPES R, R0, R1, R2 ET W SONT TELS QUE DEFINIS DANS LA DESCRIPTION, PRESENTENT DES PROPRIETES PHARMACOLOGIQUES, NOTAMMENT COMME INHIBITEURS DE L'AROMATASE
TNTNSN87033A 1986-03-07 1987-03-06 TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES TNSN87033A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/837,489 US4749713A (en) 1986-03-07 1986-03-07 Alpha-heterocycle substituted tolunitriles

Publications (1)

Publication Number Publication Date
TNSN87033A1 true TNSN87033A1 (fr) 1990-01-01

Family

ID=25274596

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN87033A TNSN87033A1 (fr) 1986-03-07 1987-03-06 TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES

Country Status (36)

Country Link
US (1) US4749713A (fr)
EP (1) EP0236940B3 (fr)
JP (1) JPH0755930B2 (fr)
KR (1) KR910000482B1 (fr)
AT (1) ATE94873T1 (fr)
BG (4) BG45700A3 (fr)
CA (1) CA1316928C (fr)
CY (1) CY1905A (fr)
CZ (3) CZ279026B6 (fr)
DD (1) DD264432A5 (fr)
DE (2) DE3787480T2 (fr)
DK (1) DK172190B1 (fr)
DZ (1) DZ1055A1 (fr)
ES (1) ES2059317T3 (fr)
FI (1) FI91857C (fr)
HK (1) HK50296A (fr)
HU (1) HU202843B (fr)
IE (1) IE61101B1 (fr)
IL (1) IL81746A (fr)
LU (1) LU90128I2 (fr)
LV (1) LV5769B4 (fr)
MA (1) MA20888A1 (fr)
MC (1) MC1805A1 (fr)
MT (1) MTP998B (fr)
MX (1) MX5496A (fr)
MY (1) MY102428A (fr)
NL (1) NL970011I2 (fr)
NO (2) NO170277C (fr)
PH (1) PH24159A (fr)
PL (2) PL152025B1 (fr)
PT (1) PT84410B (fr)
RO (2) RO101532B1 (fr)
SK (3) SK736887A3 (fr)
SU (3) SU1470184A3 (fr)
TN (1) TNSN87033A1 (fr)
ZA (1) ZA871637B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE59010171D1 (de) * 1989-07-14 1996-04-11 Ciba Geigy Ag Substituierte Benzonitrile
DE3926365A1 (de) * 1989-08-04 1991-02-07 Schering Ag Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
EP0457716A1 (fr) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Dérivés de naphtaline
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
TW210334B (fr) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
UA41295C2 (uk) 1991-09-02 2001-09-17 Яманугі Фармасетікл Ко., Лтд Триазолілзаміщені третинні амінні сполуки або їх солі як інгібітор ароматази та фармацевтична композиція на їх основі
US5223539A (en) * 1991-11-22 1993-06-29 G. D. Searle & Co. N,n-di-alkyl(phenoxy)benzamide derivatives
WO1994008973A1 (fr) * 1992-10-21 1994-04-28 Sankyo Company, Limited Compose de type azole
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US5426196A (en) * 1993-12-22 1995-06-20 Glaxo Inc. Synthesis of diaryl methanes
JP2000505797A (ja) * 1996-01-30 2000-05-16 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質転移酵素の阻害剤
AU703203B2 (en) * 1996-01-30 1999-03-18 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891360A4 (fr) * 1996-04-03 2002-05-15 Merck & Co Inc Inhibiteurs de la farnesyl-proteine transferase
JP2000507955A (ja) * 1996-04-03 2000-06-27 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質転移酵素の阻害剤
US6063930A (en) * 1996-04-03 2000-05-16 Merck & Co., Inc. Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6080870A (en) * 1996-04-03 2000-06-27 Merck & Co., Inc. Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
PL392652A1 (pl) 2001-05-16 2010-12-06 Novartis Ag Kombinacja zawierająca N-{5-[4-(4-metylo-piperazyno-metylo)-benzoiloamido]-2-metylofenylo}-4-(3-pirydylo)-2-pirymidyno-aminę oraz środek chemoterapeutyczny, jej zastosowanie, kompozycja farmaceutyczna ją zawierająca oraz zestaw zawierający taką kombinację
AU2002366587A1 (en) * 2001-12-11 2003-06-23 Emory University Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
GB0217636D0 (en) * 2002-07-30 2002-09-11 Novartis Ag Organic compounds
BR0313081A (pt) * 2002-07-30 2005-07-12 Novartis Ag Combinação de um inibidor de aromatase com um bisfosfanato
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
AU2003282380A1 (en) * 2003-11-14 2004-06-06 ADIBHATLA, KALI,SATYA, Bhujanga,rao A method for the separation of the letrozole precursor 4-1-(1,2,4-triazolyl) methyl benzonitrile from its 1,3,4-triazolyl isomer
CA2549603A1 (fr) * 2003-12-15 2005-06-30 Laboratoire Theramex Derives de 1-n-phenyl-amino-1h-imidazole et compositions pharmaceutiques les contenant
CA2608904A1 (fr) * 2005-07-06 2007-09-07 Sicor Inc. Procede ameliore de fabrication de letrozole
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US20090082413A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched letrozole
JP2013525296A (ja) 2010-04-16 2013-06-20 ノバルティス アーゲー 内分泌療法抵抗性乳癌の処置
JP5958863B2 (ja) * 2010-08-27 2016-08-02 ジェネリクス・［ユーケー］・リミテッド 純粋な中間体
PL2753312T3 (pl) * 2011-09-08 2017-06-30 Mereo Biopharma 2 Limited Zastosowanie inhibitora aromatazy w leczeniu hipogonadyzmu i powiązanych chorób
NZ702244A (en) 2012-06-08 2017-06-30 Hoffmann La Roche Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
LT3033086T (lt) 2013-08-14 2021-12-27 Novartis Ag Kombinuota terapija vėžiui gydyti
AR104068A1 (es) 2015-03-26 2017-06-21 Hoffmann La Roche Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
GB201614179D0 (en) 2016-08-19 2016-10-05 Mereo Biopharma 2 Ltd Dosage regimen for the treatment of endometriosis
BR112021001233A2 (pt) 2018-07-23 2021-04-20 F. Hoffmann-La Roche Ag método para tratar câncer em um paciente, uso de uma quantidade terapeuticamente eficaz de gdc-0077 e quantidade terapeuticamente eficaz de gdc-0077
TW202027736A (zh) 2018-10-08 2020-08-01 瑞士商赫孚孟拉羅股份公司 用PI3Kα抑制劑及二甲雙胍治療癌症之方法
JP2023504436A (ja) 2019-12-03 2023-02-03 ジェネンテック， インコーポレイテッド 乳がんの治療のための併用療法
MX2023006793A (es) 2020-12-11 2023-06-20 Genentech Inc Tratamientos conjuntos para tratamiento de cancer her2.

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290281A (en) * 1963-07-18 1966-12-06 Weinstein Julius Photochromic nitrobenzylpyridines
US3397273A (en) * 1966-02-18 1968-08-13 Lilly Co Eli Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
DE1670976B2 (de) * 1968-01-29 1976-07-22 N-trityl-imidazole
DE1908991B2 (de) * 1969-02-22 1977-05-26 Bayer Ag, 5090 Leverkusen Alpha, alpha-disubstituierte n- benzylimidazole und deren salze
BR6915465D0 (pt) * 1969-03-07 1973-01-04 Bayer Ag Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica
DE2007794A1 (de) * 1970-02-20 1971-09-02 Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen Fungizide Mittel
DE2009020C3 (de) * 1970-02-26 1979-09-13 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von N-(l,l,l-trisubstituierten)-Methylazolen
US3764690A (en) * 1972-03-03 1973-10-09 Bayer Ag Substituted n-benzylimidazoles as antimycotic agents
US3927017A (en) * 1974-06-27 1975-12-16 Janssen Pharmaceutica Nv 1-({62 -Aryl-{62 -R-ethyl)imidazoles
DE2628152C2 (de) * 1976-06-23 1985-03-28 Bayer Ag, 5090 Leverkusen Fungizide und nematizide Mittel
DE2732531A1 (de) * 1977-07-19 1979-02-01 Hoechst Ag Imidazolcarbonsaeuren und deren derivate
DE2735314A1 (de) * 1977-08-05 1979-02-22 Basf Ag Alpha-azolylsulfide und deren derivate
US4431815A (en) * 1977-08-26 1984-02-14 Burroughs Wellcome Co. 1-[3-(2,4-Dichlorophenyl)propyl]imidazole and salts thereof
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
DE2808086A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Substituierte diphenyl-imidazolyl- methane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2821829A1 (de) * 1978-05-19 1979-11-22 Basf Ag Mittel zur regulierung des pflanzenwachstums
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
DE2847441A1 (de) 1978-11-02 1980-05-22 Basf Ag Imidazol-kupferkomplexverbindungen
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
US4281141A (en) * 1980-05-30 1981-07-28 Eli Lilly And Company 3-(Imidazol-4-yl)-2-phenylpropanenitriles
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4562199A (en) * 1983-08-11 1985-12-31 Thorogood Peter B Imidazole derivatives, compositions and use
EP0149976A3 (fr) * 1983-12-30 1986-12-10 Ciba-Geigy Ag Imidazoles substitués
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
US4766140A (en) * 1984-06-18 1988-08-23 Eli Lilly And Company Method of inhibiting aromatase

Also Published As

Publication number Publication date
PL152025B1 (en) 1990-10-31
PL151490B1 (en) 1990-09-28
NL970011I2 (nl) 1997-09-01
AU6976887A (en) 1987-09-10
DE19775016I2 (de) 2002-02-21
US4749713A (en) 1988-06-07
SU1577695A3 (ru) 1990-07-07
CZ279028B6 (en) 1994-11-16
LV5769A4 (lv) 1996-12-20
CZ279027B6 (en) 1994-11-16
ZA871637B (en) 1987-10-28
ES2059317T3 (es) 1994-11-16
IL81746A0 (en) 1987-10-20
KR910000482B1 (ko) 1991-01-25
FI870903A (fi) 1987-09-08
PT84410B (pt) 1989-10-04
KR870008851A (ko) 1987-10-21
RO101532B1 (en) 1992-11-03
MTP998B (en) 1987-08-21
CZ279026B6 (en) 1994-11-16
SK279102B6 (sk) 1998-06-03
SK736787A3 (en) 1998-06-03
NO870937L (no) 1987-09-08
SK279103B6 (sk) 1998-06-03
DE3787480D1 (de) 1993-10-28
CS8707367A2 (en) 1991-02-12
FI91857B (fi) 1994-05-13
JPH0755930B2 (ja) 1995-06-14
NO170277B (no) 1992-06-22
DK117687D0 (da) 1987-03-06
JPS62212369A (ja) 1987-09-18
SK151287A3 (en) 1998-06-03
RO101533B1 (en) 1992-06-25
LV5769B4 (lv) 1997-04-20
MC1805A1 (fr) 1987-12-22
PL264460A1 (en) 1988-07-21
BG45701A3 (en) 1989-07-14
CA1316928C (fr) 1993-04-27
AU604011B2 (en) 1990-12-06
SU1549478A3 (ru) 1990-03-07
PT84410A (en) 1987-04-01
MX5496A (es) 1993-12-01
PH24159A (en) 1990-03-22
IE870575L (en) 1987-09-07
DE3787480T2 (de) 1994-02-24
CY1905A (en) 1987-03-05
EP0236940A3 (en) 1989-10-18
SK736887A3 (en) 1998-06-03
CS8707368A2 (en) 1991-02-12
FI91857C (fi) 1994-08-25
MA20888A1 (fr) 1987-10-01
NL970011I1 (nl) 1997-05-01
LU90128I2 (fr) 1997-10-06
NO1998010I1 (no) 1998-03-04
BG46598A3 (en) 1990-01-15
NO870937D0 (no) 1987-03-06
SU1470184A3 (ru) 1989-03-30
EP0236940B3 (fr) 2011-03-23
SK279101B6 (sk) 1998-06-03
DK172190B1 (da) 1997-12-22
DD264432A5 (de) 1989-02-01
HK50296A (en) 1996-03-29
ATE94873T1 (de) 1993-10-15
EP0236940B1 (fr) 1993-09-22
HU202843B (en) 1991-04-29
HUT43822A (en) 1987-12-28
IE61101B1 (en) 1994-10-05
EP0236940A2 (fr) 1987-09-16
NO170277C (no) 1992-09-30
CS8701512A2 (en) 1991-02-12
DZ1055A1 (fr) 2004-09-13
FI870903A0 (fi) 1987-03-02
BG61204B2 (bg) 1997-02-28
MY102428A (en) 1992-06-30
IL81746A (en) 1992-02-16
BG45700A3 (en) 1989-07-14
DK117687A (da) 1987-09-08

Similar Documents

Publication Publication Date Title
TNSN87033A1 (fr) TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES
ES2194987T3 (es) Compuestos triciclicos utiles para inhibir la farnesil-protein-transferasa.
NO905608D0 (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
ES2061621T3 (es) Nuevas lactamas triciclicas que contienen sulfhidrilo y sus metodos farmacologicos de uso.
IE880301L (en) Thiazolidinone derivatives, their preparation and their use
MA23355A1 (fr) COMPOSES SULFONAMIDES TRICYCLIQUES UTILES POUR l'INHIBITION DE LA FONCTION PROTEINE G
MX9202630A (es) Derivados de sulfamato anticonvulsivos.
ES2070276T3 (es) Lactonas macrociclicas inhibidoras del crecimiento celular denominadas combretastatina d-2.
FR2431505A1 (fr) Nouveaux n-(diaminophosphinyl)arylcarboxamides, utiles notamment comme inhibiteurs de l'urease
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
ES2008962A6 (es) Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
FR2394522A1 (fr) Nouveaux derives d'acides (s-phenenyl tris(carbonylimino))-5,5',5''tri-benzene-carboxyliques utiles notamment comme inhibiteurs du complement, et leur procede de preparation
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
FR2358388A1 (fr) Nouvelles 1,2,3,4-tetrahydro-4-imino-1-naphtylurees substituees, utiles notamment comme agents de croissance pour animaux, et leur procede de preparation
FR2361879A2 (fr) Nouvelles 4,5,6,7- tetrahydro-7-oxo (ou hydroxy)benzo (b)thienyl-4-amines utiles notamment comme agents de croissance pour animaux et leur procede de preparation
SE8600046D0 (sv) Use of an ester compound as a temporary bactericide and product containing said ester compound
ZA872664B (en) Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines
FR2422638A1 (fr) Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires
FR2395998A1 (fr) Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
FR2396015A1 (fr) Derives de l'acetylene, leur procede de preparation et leur utilisation comme inhibiteurs de monoamine-oxydases pour traiter notamment un etat depressif ou de l'hypertension
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
ATE100439T1 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.